SPPM interviews Dr. Gregory Hammer

Dr. Genevieve D’Souza interviewed Dr. Gregory Hammer about a new development in pain management. Oliceridine is a next generation IV opioid, as a G protein-selective agonist at the μ-opioid receptor, that is discussed in detail during this interview.
Dr. Greg Hammer is a Professor of Pediatrics and Anesthesiology, Perioperative and Pain Medicine in the Stanford University School of Medicine. Dr. Hammer’s clinical focus is in pediatric anesthesia and critical care medicine. His research is in developmental pharmacology. He has an active laboratory has published more than 100 peer-reviewed articles on topics related to the pharmacology of opioids, sedative agents and vasoactive drugs as well as organ transplantation.